Résumé
Elimination of donor-specific antibodies against HLA has been used to enable transplantation of HLA-incompatible kidneys from living donors. In contrast to two previous US studies, a UK study now reports that desensitization does not offer a survival benefit over remaining on the waitlist for a compatible organ.
Mars 2017 / Nature review nephrology – Süsal C, Opelz G
Plus d’informations : https://www.nature.com/articles/nrneph.2017.24
